For investors seeking U.S. large-cap value exposure, MGV and VTV represent two of the most cost-efficient options available, both issued by Vanguard and both built on indexes from CRSP (the Center for Research in Security Prices). Rather than competing as rivals with distinct strategies, these two ETFs sit on the same value spectrum: they share overlapping top holdings, a similar value factor tilt, and a comparable sector footprint. The core difference is breadth. This ETF comparison examines how their structural boundaries, sector exposure, and relative positioning translate into different risk, cost, and performance dynamics in the current market environment.
MGV is a passively managed ETF that seeks to track the CRSP U.S. Mega Cap Value Index, a float-adjusted, market-capitalization-weighted benchmark of the largest U.S. companies exhibiting value characteristics. Launched in December 2007, the fund holds approximately 125 stocks, concentrating its exposure in the uppermost tier of the market capitalization spectrum. Its largest positions include Berkshire Hathaway (BRK.B), JPMorgan Chase (JPM), Exxon Mobil (XOM), Johnson & Johnson (JNJ), and Walmart (WMT), with the top ten names representing roughly a quarter of total assets. Sector allocation is led by financials at about 25%, followed by health care (approximately 17%) and industrials (approximately 16%), while technology carries a modest single-digit-to-low-double-digit weight. The fund charges a 0.07% expense ratio and uses a full-replication indexing approach, rebalancing periodically to reflect index changes.
VTV is a passively managed ETF tracking the CRSP U.S. Large Cap Value Index, a broader benchmark that captures large-capitalization U.S. stocks with value characteristics. Introduced in 2004, the fund holds roughly 320 stocks, spanning a wider market-cap range within large caps. Its top holdings overlap heavily with MGV's — including Berkshire Hathaway (BRK.B), JPMorgan Chase (JPM), Exxon Mobil (XOM), and Johnson & Johnson (JNJ) — alongside names such as Chevron (CVX), AbbVie (ABBV), and Micron Technology (MU). Financials lead at roughly 21–23%, with industrials, health care, and energy as the next-largest exposures. At 0.03%, VTV's expense ratio is among the lowest in the value category, and its full-replication methodology keeps tracking tight against the index.
Both funds operate within the large-cap value segment of U.S. equities, a segment that has benefited from renewed investor interest in valuation-sensitive, cash-generating businesses. As markets rotate away from high-multiple growth and mega-cap technology leadership, capital has increasingly flowed toward financials, health care, energy, and industrials — the very sectors that dominate both portfolios. Rising-for-longer interest rate expectations have supported bank earnings, while energy exposure ties returns to commodity pricing. Regulatory scrutiny of technology concentration and shifting monetary policy expectations remain key macro drivers. The principal sector risk for both ETFs is their heavy financials weighting, which makes them sensitive to credit cycles and interest-rate volatility, while their comparatively low technology exposure could lag if growth leadership resumes.
Because both ETFs draw from overlapping value universes, their broad return profiles have historically tracked closely, though their structural differences create subtle performance divergence. VTV's larger, more diversified portfolio includes a wider set of large-cap names and carries a slightly broader technology sleeve, which has at times helped it capture momentum in select semiconductor and hardware names within the value benchmark. MGV's mega-cap focus, by contrast, produces a more concentrated, lower-turnover portfolio with greater single-stock influence from its largest financial and industrial holdings. In recent market cycles, value segments have outperformed as investors favored earnings visibility and dividend income; both funds have participated, with VTV's deeper diversification tending to reduce idiosyncratic volatility relative to MGV's tighter roster. Relative positioning hinges on whether leadership broadens across large caps or remains concentrated in the largest mega-cap names.
Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics, making it easier to identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore the AI Screener to refine your own ETF and equity research workflow.
On a structural and efficiency basis, Tickeron's AI would likely favor VTV for most long-horizon, cost-conscious investors. Its materially lower 0.03% expense ratio, broader diversification across roughly 320 holdings, and deeper liquidity provide measurable structural advantages over MGV's more concentrated mega-cap sleeve. MGV retains merit for investors seeking a purer, larger-capitalization value tilt with slightly lower beta, but its higher fee and narrower roster offer less compensation for that concentration. Barring a pronounced shift in favor of the largest mega-cap value names, the AI's probabilistic assessment leans toward VTV for cost efficiency, diversification profile, and consistent trend exposure within the large-cap value complex.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
MGV saw its Momentum Indicator move above the 0 level on October 12, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 78 similar instances where the indicator turned positive. In 67 of the 78 cases, the stock moved higher in the following days. The odds of a move higher are at 86%.
The Moving Average Convergence Divergence (MACD) for MGV just turned positive on October 08, 2026. Looking at past instances where MGV's MACD turned positive, the stock continued to rise in 38 of 52 cases over the following month. The odds of a continued upward trend are 73%.
MGV moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MGV crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.
Following a +1.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where MGV advanced for three days, in 284 of 342 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
The Aroon Indicator entered an Uptrend today. In 279 of 354 cases where MGV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.
The 10-day RSI Indicator for MGV moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 52 similar instances where the indicator moved out of overbought territory. In 31 of the 52 cases, the stock moved lower in the following days. This puts the odds of a move lower at 60%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 15 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
MGV broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
VTV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 33 of 36 cases where VTV's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on VTV as a result. In 72 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.
The Moving Average Convergence Divergence (MACD) for VTV just turned positive on October 08, 2026. Looking at past instances where VTV's MACD turned positive, the stock continued to rise in 43 of 56 cases over the following month. The odds of a continued upward trend are 77%.
VTV moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for VTV crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 77%.
Following a +1.18% 3-day Advance, the price is estimated to grow further. Considering data from situations where VTV advanced for three days, in 290 of 348 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
The Aroon Indicator entered an Uptrend today. In 278 of 351 cases where VTV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.
The 10-day RSI Indicator for VTV moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 52 similar instances where the indicator moved out of overbought territory. In 34 of the 52 cases, the stock moved lower in the following days. This puts the odds of a move lower at 65%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 16 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
| MGV | VTV | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 60% | 2 days ago 65% |
| Stochastic ODDS (%) | 2 days ago 64% | 2 days ago 65% |
| Momentum ODDS (%) | 2 days ago 86% | 2 days ago 83% |
| MACD ODDS (%) | 2 days ago 73% | 2 days ago 77% |
| TrendWeek ODDS (%) | 2 days ago 82% | 2 days ago 83% |
| TrendMonth ODDS (%) | 2 days ago 81% | 2 days ago 81% |
| Advances ODDS (%) | 3 days ago 83% | 3 days ago 83% |
| Declines ODDS (%) | N/A | N/A |
| BollingerBands ODDS (%) | 2 days ago 78% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 79% | 2 days ago 79% |
A.I.dvisor indicates that over the last year, MGV has been closely correlated with PRU. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if MGV jumps, then PRU could also see price increases.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| OOSP | 10.06 | 0.05 | +0.45% |
| Obra Opportunistic Structured Products ETF (OOSP) | |||
| VKQ | 9.08 | N/A | N/A |
| Invesco Municipal Trust | |||
| PGX | 9.84 | -0.03 | -0.30% |
| Invesco Preferred ETF (PGX) | |||
| PBFB | 32.65 | -0.21 | -0.63% |
| PGIM S&P 500 Buffer 20 ETF - February (PBFB) | |||
| IBRN | 32.84 | -0.45 | -1.35% |
| iShares Neuroscience and Healthcare ETF (IBRN) | |||